.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Quality Drugs has shown a notable performance in the Edible category in Oregon. Over the last few months of 2025, the brand has consistently improved its ranking, moving from 13th position in September to securing the 10th spot by November and maintaining it through December. This upward trajectory is accompanied by a steady increase in sales, indicating a growing consumer preference for their edible products. Such consistent progress in a competitive market like Oregon suggests that Quality Drugs is successfully capturing consumer interest and expanding its market share in the Edible category.
While Quality Drugs has made significant strides in Oregon's Edible segment, the absence of rankings in other states or categories highlights potential areas for growth. The lack of presence in the top 30 brands in other regions or product categories could be seen as a missed opportunity, suggesting that the brand might need to explore diversification or expansion strategies to enhance its market footprint. This gap presents both a challenge and an opportunity for Quality Drugs to leverage its success in Oregon and replicate it across different states or product lines.
Competitive Landscape
In the competitive landscape of the Oregon edible cannabis market, Quality Drugs has demonstrated a promising upward trajectory in recent months. From September to December 2025, Quality Drugs improved its rank from 13th to 10th, indicating a positive shift in market positioning. This upward movement is complemented by a steady increase in sales, showcasing the brand's growing consumer appeal. Notably, competitors such as Private Stash and Hellavated have maintained relatively stable ranks, with Private Stash consistently outperforming Quality Drugs in terms of rank, though the gap is narrowing. Meanwhile, Verdant Leaf Farms experienced a decline in rank from 9th to 12th, potentially providing Quality Drugs with an opportunity to capture some of their market share. The data suggests that Quality Drugs is on a positive growth path, with the potential to further enhance its market position if current trends continue.
Notable Products
In December 2025, the top-performing product from Quality Drugs was the Cosmic Pop Gummy (100mg) in the Edible category, maintaining its first-place ranking from previous months with an impressive sales figure of 4,011 units. The Super Sour Apple Gummy (100mg) climbed back into the rankings at second place, showing a significant increase from its absence in November. Lifted Lime Gummy (100mg) secured the third position, marking its return to the top three since September. Meanwhile, Mellow Mango Gummy (100mg) saw a slight decline, dropping to fourth place despite consistent sales. A new entry, the CBD/CBN/THC 1:1:1 Berry Bonanza Gumdrops 10-Pack (100mg CBD, 100mg CBN, 100mg THC), emerged in fifth place, highlighting its growing popularity.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
